Allakos Inc. (ALLK) Stock: A Strong Pick In The Biotechnology Industry?


Allakos Inc. (ALLK) is making a move down in the market today. The company, one that is focused on the biotechnology space, is currently priced at $41.14 after falling -7.01% so far today. As it relates to biotech stocks, there are quite a few factors that have the potential to generate declines in the market. News tends to be one of the biggest reasons for the movement. Here are the recent headlines centered around ALLK:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jun-19-19 07:10AM Ohio Capital Fund’s management firm seeks 3-year extension, raise
May-08-19 08:01AM Allakos Reports First Quarter 2019 Financial Results
May-07-19 04:01PM Allakos Announces Positive Results with AK002 in Patients with Severe Allergic Conjunctivitis
May-01-19 12:17PM Is Allakos Inc. (ALLK) A Good Stock To Buy?
Mar-14-19 04:01PM Allakos Reports Fourth Quarter and Full Year 2018 Financial Results and 2018 Corporate Highlights

Nonetheless, any time investors are making a decision to invest, prospective investors should look at far more than just news, this is especially the case in the highly speculative biotech industry. Here’s what’s happing when it comes to Allakos Inc..

Recent Moves From ALLK

Although a decline in a single session, like the move that we’re seeing from Allakos Inc. might cause fear in some investors, that by itself should not be the basis of a decision to, or not to, invest in a company. It is always a good idea to look at trends for a period longer than a single trading day. When it comes to ALLK, here are the movements that we have seen:

  • Past 5 Sessions – Over the last week, ALLK has generated a price change amounting to -4.99%.
  • Past 30 Days – The return from Allakos Inc. in the last 30 days has been -5.79%.
  • Past Three Months – Throughout the past 3 months, the stock has produced a ROI that works out to 12.10%
  • Past Six Months – Over the last six months, we’ve seen a change of -18.11% from the company.
  • Year To Date – Since the the last trading session of last year ALLK has produced a ROI of -21.29%.
  • Annually – Finally, in the past year, investors have seen movement of 0 from ALLK. In this period, the stock has sold at a high of -37.17% and a low of 58.23%.

Rations That Investors Should Think About

Digging into various key ratios associated with a stock can provide investors a view of just how dangerous and/or rewarding a an investment option might be. Below are a few of the most important ratios to consider when digging into ALLK.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors are expecting that the value of the stock is headed for declines. Across the sector, biotech stocks can carry a higher short ratio. However, we also see a lot of short squeezes in the sector. Nonetheless, as it relates to Allakos Inc., it’s short ratio amounts to 17.12.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Basically, they measure If a company is able to pay for its debts as they mature based on quick assets or current assets. Because many biotech companies are reliant on continued investor support, the current and quick ratios can be bad. However, some good picks in the biotechnology industry do have positive quick and current ratios. In terms of ALLK, the quick and current ratios total up to 20.50 and 20.50 respectively.  

Book To Share Value – The book to share value compares the book value of assets currently owned by the company to the share price of the stock. In this particular case, that ratio works out to 3.94.

Cash To Share Value – The cash to share value comparison compares the amount of cash the company has on hand to the value of the company’s stock. Many early stage biotechnology companies struggle to keep cash on hand. So, if you’re considering an investment in a stock in the biotechnology space, this is a very important ratio to think about. In the case of ALLK, the cash to share value ratio works out to 3.84.

How Analysts Feel About Allakos Inc.

While it’s not a good idea to avoid doing your due diligence and blindly following the opinions of analysts, it is a smart idea to use their thoughts when validating your own thoughts when it comes to making investment decisions in the biotechnology industry. Below are the most recent moves that we’ve seen from analysts as it relates to ALLK.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Aug-13-18 Initiated William Blair Outperform
Aug-13-18 Initiated Jefferies Buy $53
Aug-13-18 Initiated Goldman Neutral $31

Big Money And Allakos Inc.

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in ALLK, here’s what we’re seeing:

  • Institutional Investors – As it stands now, institutional investors hold 97.60% of Allakos Inc.. Nonetheless, it’s worth considering that the ownership held by institutions has seen a move of 15.34% in the last quarter.
  • Insider Holdings – As far as insiders go, those close to the situation currently own 0 of Allakos Inc.. Their ownership of the company has moved 0 throughout the past quarter.

Interested In How Many Shares Are Available?

Traders tend to like to know the amounts of shares both available and outstanding. With respect to Allakos Inc., currently there are 43.50M and there is a float of 43.12M. These data mean that of the total of 43.50M shares of ALLK currently in existence today, 43.12M are available to be traded on the public market.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to ALLK, the short percent of the float is 11.16%.


What have ween seen from ALLK in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – Currently, Wall Street analysts have expectations that ALLK will create EPS that comes to -2.23, with -0.45 to be reported in the earnings announcement for the current quarter. Although this data isn’t earnings driven, because we’re chatting about Wall St. analysts, the stock is currently graded as a 1.70 when rated on a scale from 1 to 5 where 1 is the worst possible analyst rating and 5 is the best possible.
  • 5-Year Sales – Throughout the last 5 years, Allakos Inc. has created a movement in sales volume that comes to a total of 0. Earnings per diluted share through the period have generated a change of 0.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings data, or Q/Q data as it is often referred to as in the world of humans, the company has generated a change in earnings in the amount of -123.30%. The company has also experienced movement in regard to revenue that comes to a total of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. Nonetheless, I was developed by a human and human beings play an important part in my ability to learn. Sure, I can comb through social media trends and other publicly available data, but I am able to learn much faster when I have a teacher. If you would to help me learn something, I would love to learn! Is there other data that captures your interest? Am I saying something wrong? Is there another way to look at data? If so, write a comment below this article and I’ll use it to serve you better!


Please enter your comment!
Please enter your name here